Greystone

Greystone Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of advanced wound care and dermatology products. The company's core technology is based on its proprietary Poly-Hydrated Ion (PHI) platform, which utilizes a unique ionic formulation to promote tissue repair and manage chronic wounds. Greystone has successfully brought several PHI-based products to market, often through strategic partnerships with major healthcare companies like 3M. Their portfolio addresses significant unmet needs in the treatment of diabetic foot ulcers, pressure sores, and other complex dermatological conditions. By leveraging its specialized delivery systems, Greystone aims to improve patient outcomes in the high-growth wound management sector.